Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	gamma-aminobutyric acid:sodium:chloride symporter activity	SLC6A8 SLC6A12 SLC6A13	2.32e-08	6	22	3	GO:0005332
GeneOntologyMolecularFunction	gamma-aminobutyric acid transmembrane transporter activity	SLC6A8 SLC6A12 SLC6A13	9.71e-08	9	22	3	GO:0015185
GeneOntologyMolecularFunction	monocarboxylate:sodium symporter activity	SLC6A8 SLC6A12 SLC6A13	5.24e-07	15	22	3	GO:0140161
GeneOntologyMolecularFunction	sodium:chloride symporter activity	SLC6A8 SLC6A12 SLC6A13	7.81e-07	17	22	3	GO:0015378
GeneOntologyMolecularFunction	monoatomic anion:sodium symporter activity	SLC6A8 SLC6A12 SLC6A13	1.11e-06	19	22	3	GO:0015373
GeneOntologyMolecularFunction	secondary active monocarboxylate transmembrane transporter activity	SLC6A8 SLC6A12 SLC6A13	1.11e-06	19	22	3	GO:0015355
GeneOntologyMolecularFunction	chloride:monoatomic cation symporter activity	SLC6A8 SLC6A12 SLC6A13	2.03e-06	23	22	3	GO:0015377
GeneOntologyMolecularFunction	amino acid:sodium symporter activity	SLC6A8 SLC6A12 SLC6A13	2.03e-06	23	22	3	GO:0005283
GeneOntologyMolecularFunction	monoatomic anion:monoatomic cation symporter activity	SLC6A8 SLC6A12 SLC6A13	2.97e-06	26	22	3	GO:0015296
GeneOntologyMolecularFunction	amino acid:monoatomic cation symporter activity	SLC6A8 SLC6A12 SLC6A13	4.16e-06	29	22	3	GO:0005416
GeneOntologyMolecularFunction	creatine transmembrane transporter activity	SLC6A8 SLC6A13	6.94e-06	4	22	2	GO:0005308
GeneOntologyMolecularFunction	glucuronosyltransferase activity	UGT2B11 UGT2B10 UGT2B28	7.43e-06	35	22	3	GO:0015020
GeneOntologyMolecularFunction	organic acid:sodium symporter activity	SLC6A8 SLC6A12 SLC6A13	7.43e-06	35	22	3	GO:0005343
GeneOntologyMolecularFunction	transforming growth factor beta receptor activity, type I	BMPR1A BMPR1B	1.16e-05	5	22	2	GO:0005025
GeneOntologyMolecularFunction	BMP receptor activity	BMPR1A BMPR1B	3.23e-05	8	22	2	GO:0098821
GeneOntologyMolecularFunction	transforming growth factor beta receptor activity	BMPR1A BMPR1B	8.97e-05	13	22	2	GO:0005024
GeneOntologyMolecularFunction	solute:sodium symporter activity	SLC6A8 SLC6A12 SLC6A13	9.37e-05	81	22	3	GO:0015370
GeneOntologyMolecularFunction	monocarboxylic acid transmembrane transporter activity	SLC6A8 SLC6A12 SLC6A13	1.28e-04	90	22	3	GO:0008028
GeneOntologyMolecularFunction	endopeptidase activator activity	APH1B NLRC4	1.96e-04	19	22	2	GO:0061133
GeneOntologyMolecularFunction	amino acid transmembrane transporter activity	SLC6A8 SLC6A12 SLC6A13	2.02e-04	105	22	3	GO:0015171
GeneOntologyMolecularFunction	transmembrane receptor protein serine/threonine kinase activity	BMPR1A BMPR1B	2.18e-04	20	22	2	GO:0004675
GeneOntologyMolecularFunction	BMP binding	BMPR1A BMPR1B	2.64e-04	22	22	2	GO:0036122
GeneOntologyMolecularFunction	solute:monoatomic cation symporter activity	SLC6A8 SLC6A12 SLC6A13	2.93e-04	119	22	3	GO:0015294
GeneOntologyMolecularFunction	chloride transmembrane transporter activity	SLC6A8 SLC6A12 SLC6A13	3.38e-04	125	22	3	GO:0015108
GeneOntologyMolecularFunction	symporter activity	SLC6A8 SLC6A12 SLC6A13	5.76e-04	150	22	3	GO:0015293
GeneOntologyMolecularFunction	monoatomic anion transmembrane transporter activity	SLC6A8 SLC6A12 SLC6A13	5.87e-04	151	22	3	GO:0008509
GeneOntologyMolecularFunction	modified amino acid transmembrane transporter activity	SLC6A8 SLC6A13	5.99e-04	33	22	2	GO:0072349
GeneOntologyMolecularFunction	UDP-glycosyltransferase activity	UGT2B11 UGT2B10 UGT2B28	6.10e-04	153	22	3	GO:0008194
GeneOntologyMolecularFunction	sodium ion transmembrane transporter activity	SLC6A8 SLC6A12 SLC6A13	8.43e-04	171	22	3	GO:0015081
GeneOntologyMolecularFunction	inorganic anion transmembrane transporter activity	SLC6A8 SLC6A12 SLC6A13	8.43e-04	171	22	3	GO:0015103
GeneOntologyMolecularFunction	carboxylic acid transmembrane transporter activity	SLC6A8 SLC6A12 SLC6A13	1.46e-03	207	22	3	GO:0046943
GeneOntologyMolecularFunction	organic acid transmembrane transporter activity	SLC6A8 SLC6A12 SLC6A13	1.48e-03	208	22	3	GO:0005342
GeneOntologyMolecularFunction	hexosyltransferase activity	UGT2B11 UGT2B10 UGT2B28	1.54e-03	211	22	3	GO:0016758
GeneOntologyMolecularFunction	peptidase activator activity	APH1B NLRC4	2.67e-03	70	22	2	GO:0016504
GeneOntologyMolecularFunction	glycosyltransferase activity	UGT2B11 UGT2B10 UGT2B28	3.73e-03	288	22	3	GO:0016757
GeneOntologyMolecularFunction	transmembrane receptor protein kinase activity	BMPR1A BMPR1B	3.91e-03	85	22	2	GO:0019199
GeneOntologyMolecularFunction	organic anion transmembrane transporter activity	SLC6A8 SLC6A12 SLC6A13	3.92e-03	293	22	3	GO:0008514
GeneOntologyMolecularFunction	SMAD binding	BMPR1A BMPR1B	4.00e-03	86	22	2	GO:0046332
GeneOntologyMolecularFunction	secondary active transmembrane transporter activity	SLC6A8 SLC6A12 SLC6A13	4.03e-03	296	22	3	GO:0015291
GeneOntologyMolecularFunction	active monoatomic ion transmembrane transporter activity	SLC6A8 SLC6A12 SLC6A13	4.22e-03	301	22	3	GO:0022853
GeneOntologyMolecularFunction	cytokine binding	BMPR1A BMPR1B	1.28e-02	157	22	2	GO:0019955
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	SLC6A8 SLC6A12 SLC6A13	1.39e-02	465	22	3	GO:0046873
GeneOntologyMolecularFunction	active transmembrane transporter activity	SLC6A8 SLC6A12 SLC6A13	1.49e-02	477	22	3	GO:0022804
GeneOntologyMolecularFunction	serine-type endopeptidase activity	MMP14 IMMP2L	1.84e-02	190	22	2	GO:0004252
GeneOntologyBiologicalProcess	biphenyl catabolic process	UGT2B11 UGT2B10 UGT2B28	5.88e-08	8	22	3	GO:0070980
GeneOntologyBiologicalProcess	androgen metabolic process	UGT2B11 UGT2B10 INHBA UGT2B28	6.99e-08	38	22	4	GO:0008209
GeneOntologyBiologicalProcess	biphenyl metabolic process	UGT2B11 UGT2B10 UGT2B28	1.26e-07	10	22	3	GO:0018879
GeneOntologyBiologicalProcess	xenobiotic glucuronidation	UGT2B11 UGT2B10 UGT2B28	2.30e-07	12	22	3	GO:0052697
GeneOntologyBiologicalProcess	estrogen metabolic process	UGT2B11 UGT2B10 BMPR1B UGT2B28	2.54e-07	52	22	4	GO:0008210
GeneOntologyBiologicalProcess	cellular glucuronidation	UGT2B11 UGT2B10 UGT2B28	1.38e-06	21	22	3	GO:0052695
GeneOntologyBiologicalProcess	ovarian follicle development	MMP14 IMMP2L INHBA BMPR1B	2.04e-06	87	22	4	GO:0001541
GeneOntologyBiologicalProcess	glucuronate metabolic process	UGT2B11 UGT2B10 UGT2B28	2.70e-06	26	22	3	GO:0019585
GeneOntologyBiologicalProcess	uronic acid metabolic process	UGT2B11 UGT2B10 UGT2B28	2.70e-06	26	22	3	GO:0006063
GeneOntologyBiologicalProcess	gamma-aminobutyric acid transport	SLC6A8 SLC6A12 SLC6A13	3.39e-06	28	22	3	GO:0015812
GeneOntologyBiologicalProcess	gamma-aminobutyric acid reuptake	SLC6A12 SLC6A13	6.51e-06	4	22	2	GO:0051936
GeneOntologyBiologicalProcess	creatine transmembrane transport	SLC6A8 SLC6A13	6.51e-06	4	22	2	GO:0015881
GeneOntologyBiologicalProcess	mesodermal cell differentiation	INHBA TRIM15 BMPR1A	6.74e-06	35	22	3	GO:0048333
GeneOntologyBiologicalProcess	benzene-containing compound metabolic process	UGT2B11 UGT2B10 UGT2B28	7.99e-06	37	22	3	GO:0042537
GeneOntologyBiologicalProcess	xenobiotic catabolic process	UGT2B11 UGT2B10 UGT2B28	7.99e-06	37	22	3	GO:0042178
GeneOntologyBiologicalProcess	hormone metabolic process	UGT2B11 UGT2B10 INHBA BMPR1B UGT2B28	1.07e-05	286	22	5	GO:0042445
GeneOntologyBiologicalProcess	female gonad development	MMP14 IMMP2L INHBA BMPR1B	1.28e-05	138	22	4	GO:0008585
GeneOntologyBiologicalProcess	modified amino acid transport	SLC6A8 SLC6A12 SLC6A13	1.36e-05	44	22	3	GO:0072337
GeneOntologyBiologicalProcess	development of primary female sexual characteristics	MMP14 IMMP2L INHBA BMPR1B	1.43e-05	142	22	4	GO:0046545
GeneOntologyBiologicalProcess	female sex differentiation	MMP14 IMMP2L INHBA BMPR1B	2.12e-05	157	22	4	GO:0046660
GeneOntologyBiologicalProcess	sex differentiation	MMP14 IMMP2L INHBA BMPR1A BMPR1B	2.92e-05	352	22	5	GO:0007548
GeneOntologyBiologicalProcess	steroid metabolic process	UGT2B11 UGT2B10 INHBA BMPR1B UGT2B28	4.00e-05	376	22	5	GO:0008202
GeneOntologyBiologicalProcess	amino acid neurotransmitter reuptake	SLC6A12 SLC6A13	4.86e-05	10	22	2	GO:0051933
GeneOntologyBiologicalProcess	regulation of hormone levels	UGT2B11 UGT2B10 INHBA BMPR1B FFAR4 UGT2B28	6.16e-05	684	22	6	GO:0010817
GeneOntologyBiologicalProcess	mesoderm formation	INHBA TRIM15 BMPR1A	8.83e-05	82	22	3	GO:0001707
GeneOntologyBiologicalProcess	mesoderm morphogenesis	INHBA TRIM15 BMPR1A	1.02e-04	86	22	3	GO:0048332
GeneOntologyBiologicalProcess	positive regulation of osteoblast differentiation	BMPR1A BMPR1B FFAR4	1.09e-04	88	22	3	GO:0045669
GeneOntologyBiologicalProcess	protein processing	MMP14 IMMP2L APH1B NLRC4	2.15e-04	285	22	4	GO:0016485
GeneOntologyBiologicalProcess	gonad development	MMP14 IMMP2L INHBA BMPR1B	2.35e-04	292	22	4	GO:0008406
GeneOntologyBiologicalProcess	development of primary sexual characteristics	MMP14 IMMP2L INHBA BMPR1B	2.51e-04	297	22	4	GO:0045137
GeneOntologyBiologicalProcess	mesodermal cell fate commitment	TRIM15 BMPR1A	2.71e-04	23	22	2	GO:0001710
GeneOntologyBiologicalProcess	ovulation	IMMP2L INHBA	2.96e-04	24	22	2	GO:0030728
GeneOntologyBiologicalProcess	formation of primary germ layer	INHBA TRIM15 BMPR1A	3.00e-04	124	22	3	GO:0001704
GeneOntologyBiologicalProcess	xenobiotic metabolic process	UGT2B11 UGT2B10 UGT2B28	4.38e-04	141	22	3	GO:0006805
GeneOntologyBiologicalProcess	positive regulation of protein processing	MMP14 NLRC4	4.96e-04	31	22	2	GO:0010954
GeneOntologyBiologicalProcess	chondrocyte proliferation	MMP14 BMPR1B	4.96e-04	31	22	2	GO:0035988
GeneOntologyBiologicalProcess	regulation of cytokine production	IRF8 INHBA TRIM15 BMPR1A NLRC4 FFAR4	5.15e-04	1010	22	6	GO:0001817
GeneOntologyBiologicalProcess	positive regulation of gene expression	IRF8 MMP14 INHBA TRIM15 BMPR1A BMPR1B NLRC4	5.48e-04	1446	22	7	GO:0010628
GeneOntologyBiologicalProcess	positive regulation of protein maturation	MMP14 NLRC4	5.62e-04	33	22	2	GO:1903319
GeneOntologyBiologicalProcess	mesoderm development	INHBA TRIM15 BMPR1A	5.99e-04	157	22	3	GO:0007498
GeneOntologyBiologicalProcess	reproductive structure development	MMP14 IMMP2L INHBA BMPR1B	6.57e-04	383	22	4	GO:0048608
GeneOntologyBiologicalProcess	reproductive system development	MMP14 IMMP2L INHBA BMPR1B	6.90e-04	388	22	4	GO:0061458
GeneOntologyBiologicalProcess	cell fate commitment involved in formation of primary germ layer	TRIM15 BMPR1A	7.07e-04	37	22	2	GO:0060795
GeneOntologyBiologicalProcess	neurotransmitter reuptake	SLC6A12 SLC6A13	7.46e-04	38	22	2	GO:0098810
GeneOntologyBiologicalProcess	cytokine production	IRF8 INHBA TRIM15 BMPR1A NLRC4 FFAR4	7.75e-04	1091	22	6	GO:0001816
GeneOntologyBiologicalProcess	positive regulation of SMAD protein signal transduction	INHBA BMPR1A	9.55e-04	43	22	2	GO:0060391
GeneOntologyBiologicalProcess	regulation of osteoblast differentiation	BMPR1A BMPR1B FFAR4	1.07e-03	192	22	3	GO:0045667
GeneOntologyBiologicalProcess	regulation of B cell differentiation	MMP14 INHBA	1.09e-03	46	22	2	GO:0045577
GeneOntologyBiologicalProcess	amino acid transport	SLC6A8 SLC6A12 SLC6A13	1.12e-03	195	22	3	GO:0006865
GeneOntologyBiologicalProcess	male sex differentiation	MMP14 INHBA BMPR1A	1.19e-03	199	22	3	GO:0046661
GeneOntologyBiologicalProcess	B cell differentiation	IRF8 MMP14 INHBA	1.22e-03	201	22	3	GO:0030183
GeneOntologyBiologicalProcess	positive regulation of bone mineralization	BMPR1A BMPR1B	1.24e-03	49	22	2	GO:0030501
GeneOntologyBiologicalProcess	sodium ion transmembrane transport	SLC6A8 SLC6A12 SLC6A13	1.35e-03	208	22	3	GO:0035725
GeneOntologyBiologicalProcess	neurotransmitter uptake	SLC6A12 SLC6A13	1.39e-03	52	22	2	GO:0001504
GeneOntologyBiologicalProcess	gastrulation	INHBA TRIM15 BMPR1A	1.43e-03	212	22	3	GO:0007369
GeneOntologyBiologicalProcess	monocarboxylic acid transport	SLC6A8 SLC6A12 SLC6A13	1.45e-03	213	22	3	GO:0015718
GeneOntologyBiologicalProcess	central nervous system neuron differentiation	INHBA BMPR1A BMPR1B	1.53e-03	217	22	3	GO:0021953
GeneOntologyBiologicalProcess	cellular catabolic process	UGT2B11 IRF8 UGT2B10 INHBA ATG16L1 UGT2B28	1.59e-03	1253	22	6	GO:0044248
GeneOntologyBiologicalProcess	cellular response to xenobiotic stimulus	UGT2B11 UGT2B10 UGT2B28	1.63e-03	222	22	3	GO:0071466
GeneOntologyBiologicalProcess	female gamete generation	IMMP2L INHBA BMPR1B	1.65e-03	223	22	3	GO:0007292
GeneOntologyBiologicalProcess	positive regulation of biomineral tissue development	BMPR1A BMPR1B	1.85e-03	60	22	2	GO:0070169
GeneOntologyBiologicalProcess	positive regulation of extrinsic apoptotic signaling pathway	INHBA BMPR1B	2.04e-03	63	22	2	GO:2001238
GeneOntologyBiologicalProcess	zymogen activation	MMP14 NLRC4	2.17e-03	65	22	2	GO:0031638
GeneOntologyBiologicalProcess	positive regulation of ossification	BMPR1A BMPR1B	2.24e-03	66	22	2	GO:0045778
GeneOntologyBiologicalProcess	ovulation cycle process	INHBA BMPR1B	2.37e-03	68	22	2	GO:0022602
GeneOntologyBiologicalProcess	head development	MMP14 IMMP2L INHBA ATG16L1 BMPR1A	2.43e-03	919	22	5	GO:0060322
GeneOntologyBiologicalProcess	neurotransmitter transport	SLC6A8 SLC6A12 SLC6A13	2.53e-03	259	22	3	GO:0006836
GeneOntologyBiologicalProcess	ossification	MMP14 BMPR1A BMPR1B FFAR4	2.70e-03	562	22	4	GO:0001503
GeneOntologyBiologicalProcess	sodium ion transport	SLC6A8 SLC6A12 SLC6A13	2.99e-03	275	22	3	GO:0006814
GeneOntologyBiologicalProcess	positive regulation of cytokine production	IRF8 TRIM15 BMPR1A NLRC4	3.14e-03	586	22	4	GO:0001819
GeneOntologyBiologicalProcess	endochondral bone morphogenesis	MMP14 BMPR1B	3.18e-03	79	22	2	GO:0060350
GeneOntologyBiologicalProcess	regulation of protein processing	MMP14 NLRC4	3.43e-03	82	22	2	GO:0070613
GeneOntologyBiologicalProcess	regulation of protein maturation	MMP14 NLRC4	3.76e-03	86	22	2	GO:1903317
GeneOntologyCellularComponent	nuclear outer membrane	UGT2B11 UGT2B10 UGT2B28	9.75e-06	40	22	3	GO:0005640
GeneOntologyCellularComponent	HFE-transferrin receptor complex	BMPR1A BMPR1B	2.95e-05	8	22	2	GO:1990712
GeneOntologyCellularComponent	organelle outer membrane	UGT2B11 UGT2B10 UGT2B28	3.00e-03	279	22	3	GO:0031968
GeneOntologyCellularComponent	outer membrane	UGT2B11 UGT2B10 UGT2B28	3.06e-03	281	22	3	GO:0019867
Domain	NA_NEUROTRAN_SYMP_2	SLC6A8 SLC6A12 SLC6A13	1.14e-06	18	22	3	PS00754
Domain	SNF	SLC6A8 SLC6A12 SLC6A13	1.36e-06	19	22	3	PF00209
Domain	NA_NEUROTRAN_SYMP_3	SLC6A8 SLC6A12 SLC6A13	1.36e-06	19	22	3	PS50267
Domain	Na/ntran_symport	SLC6A8 SLC6A12 SLC6A13	1.36e-06	19	22	3	IPR000175
Domain	NA_NEUROTRAN_SYMP_1	SLC6A8 SLC6A12 SLC6A13	1.36e-06	19	22	3	PS00610
Domain	UDPGT	UGT2B11 UGT2B10 UGT2B28	1.86e-06	21	22	3	PS00375
Domain	UDPGT	UGT2B11 UGT2B10 UGT2B28	1.86e-06	21	22	3	PF00201
Domain	UDP_glucos_trans	UGT2B11 UGT2B10 UGT2B28	1.86e-06	21	22	3	IPR002213
Domain	GS	BMPR1A BMPR1B	2.77e-05	7	22	2	SM00467
Domain	TGF_beta_GS	BMPR1A BMPR1B	2.77e-05	7	22	2	PF08515
Domain	GS	BMPR1A BMPR1B	2.77e-05	7	22	2	PS51256
Domain	GS_dom	BMPR1A BMPR1B	2.77e-05	7	22	2	IPR003605
Domain	Activin_recp	BMPR1A BMPR1B	5.93e-05	10	22	2	IPR000472
Domain	Activin_recp	BMPR1A BMPR1B	5.93e-05	10	22	2	PF01064
Domain	TGFB_receptor	BMPR1A BMPR1B	8.68e-05	12	22	2	IPR000333
Domain	G-protein_beta_WD-40_rep	ATG16L1 TBL2	4.46e-03	85	22	2	IPR020472
Domain	Pkinase_Tyr	BMPR1A BMPR1B	9.99e-03	129	22	2	PF07714
Domain	Ser-Thr/Tyr_kinase_cat_dom	BMPR1A BMPR1B	1.14e-02	138	22	2	IPR001245
Domain	WD40_repeat_CS	ATG16L1 TBL2	1.58e-02	164	22	2	IPR019775
Pathway	REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS	MMP14 INHBA APH1B BMPR1A BMPR1B	6.90e-07	118	21	5	MM15588
Pathway	REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS	MMP14 INHBA APH1B BMPR1A BMPR1B	3.20e-06	161	21	5	M27871
Pathway	REACTOME_SIGNALING_BY_TGFBR3	MMP14 INHBA APH1B	3.72e-06	21	21	3	MM17231
Pathway	REACTOME_PREDNISONE_ADME	UGT2B11 UGT2B10 UGT2B28	4.95e-06	23	21	3	MM16639
Pathway	REACTOME_GLUCURONIDATION	UGT2B11 UGT2B10 UGT2B28	5.65e-06	24	21	3	MM14599
Pathway	WP_GLUCURONIDATION	UGT2B11 UGT2B10 UGT2B28	6.42e-06	25	21	3	MM15820
Pathway	REACTOME_GLUCURONIDATION	UGT2B11 UGT2B10 UGT2B28	6.42e-06	25	21	3	M17787
Pathway	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	UGT2B11 UGT2B10 UGT2B28	6.42e-06	25	21	3	M605
Pathway	WP_GLUCURONIDATION	UGT2B11 UGT2B10 UGT2B28	7.25e-06	26	21	3	M39404
Pathway	KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS	UGT2B11 UGT2B10 UGT2B28	9.11e-06	28	21	3	M19580
Pathway	REACTOME_SIGNALING_BY_BMP	INHBA BMPR1A BMPR1B	1.25e-05	31	21	3	M1662
Pathway	REACTOME_SIGNALING_BY_BMP	INHBA BMPR1A BMPR1B	1.25e-05	31	21	3	MM14789
Pathway	REACTOME_PARACETAMOL_ADME	UGT2B11 UGT2B10 UGT2B28	2.52e-05	39	21	3	MM15695
Pathway	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	UGT2B11 UGT2B10 UGT2B28	2.93e-05	41	21	3	M7399
Pathway	REACTOME_ASPIRIN_ADME	UGT2B11 UGT2B10 UGT2B28	3.63e-05	44	21	3	M45014
Pathway	REACTOME_ASPIRIN_ADME	UGT2B11 UGT2B10 UGT2B28	3.88e-05	45	21	3	MM15694
Pathway	REACTOME_SIGNALING_BY_TGFBR3	MMP14 INHBA APH1B	5.02e-05	49	21	3	M48250
Pathway	KEGG_DRUG_METABOLISM_OTHER_ENZYMES	UGT2B11 UGT2B10 UGT2B28	5.67e-05	51	21	3	M17726
Pathway	KEGG_STARCH_AND_SUCROSE_METABOLISM	UGT2B11 UGT2B10 UGT2B28	6.01e-05	52	21	3	M14171
Pathway	KEGG_STEROID_HORMONE_BIOSYNTHESIS	UGT2B11 UGT2B10 UGT2B28	7.11e-05	55	21	3	M14933
Pathway	KEGG_MEDICUS_REFERENCE_AMH_SIGNALING_PATHWAY	BMPR1A BMPR1B	7.56e-05	9	21	2	M47844
Pathway	REACTOME_TGFBR3_PTM_REGULATION	MMP14 APH1B	9.44e-05	10	21	2	MM17232
Pathway	KEGG_RETINOL_METABOLISM	UGT2B11 UGT2B10 UGT2B28	1.12e-04	64	21	3	M9488
Pathway	REACTOME_TGFBR3_PTM_REGULATION	MMP14 APH1B	1.15e-04	11	21	2	M48251
Pathway	REACTOME_CREATINE_METABOLISM	SLC6A8 SLC6A12	1.15e-04	11	21	2	M27681
Pathway	REACTOME_CREATINE_METABOLISM	SLC6A8 SLC6A12	1.15e-04	11	21	2	MM15402
Pathway	WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION	BMPR1A BMPR1B	1.38e-04	12	21	2	M39519
Pathway	KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	UGT2B11 UGT2B10 UGT2B28	1.46e-04	70	21	3	M16794
Pathway	KEGG_DRUG_METABOLISM_CYTOCHROME_P450	UGT2B11 UGT2B10 UGT2B28	1.59e-04	72	21	3	M9257
Pathway	KEGG_TGF_BETA_SIGNALING_PATHWAY	INHBA BMPR1A BMPR1B	2.69e-04	86	21	3	M2642
Pathway	REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION	SLC6A12 SLC6A13	3.56e-04	19	21	2	M927
Pathway	REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS	SLC6A12 SLC6A13	3.56e-04	19	21	2	MM15107
Pathway	REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS	SLC6A12 SLC6A13	3.56e-04	19	21	2	M27362
Pathway	REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION	SLC6A12 SLC6A13	3.56e-04	19	21	2	MM15523
Pathway	KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY	BMPR1A BMPR1B	3.95e-04	20	21	2	M47843
Pathway	REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS	UGT2B11 UGT2B10 UGT2B28	5.12e-04	107	21	3	MM14595
Pathway	REACTOME_DRUG_ADME	UGT2B11 UGT2B10 UGT2B28	5.40e-04	109	21	3	M45012
Pathway	REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS	UGT2B11 UGT2B10 UGT2B28	5.40e-04	109	21	3	M18788
Pathway	REACTOME_DRUG_ADME	UGT2B11 UGT2B10 UGT2B28	6.98e-04	119	21	3	MM15692
Pathway	PID_BMP_PATHWAY	BMPR1A BMPR1B	1.76e-03	42	21	2	M181
Pathway	REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE	SLC6A12 SLC6A13	2.58e-03	51	21	2	MM14499
Pathway	REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE	SLC6A12 SLC6A13	2.58e-03	51	21	2	M4281
Pathway	WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME	BMPR1A BMPR1B	3.67e-03	61	21	2	M48077
Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	UGT2B11 UGT2B10 UGT2B28	4.00e-03	219	21	3	MM14838
Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	UGT2B11 UGT2B10 UGT2B28	4.05e-03	220	21	3	M10320
Pathway	REACTOME_PEPTIDE_HORMONE_METABOLISM	INHBA FFAR4	4.80e-03	70	21	2	MM14916
Pathway	REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS	SLC6A12 SLC6A13	5.64e-03	76	21	2	MM15072
Pathway	WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION	INHBA BMPR1A BMPR1B	6.05e-03	254	21	3	M48344
Pathway	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	INHBA BMPR1A BMPR1B	6.73e-03	264	21	3	M9809
Pathway	REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS	SLC6A12 SLC6A13	6.85e-03	84	21	2	M27334
Pathway	REACTOME_PEPTIDE_HORMONE_METABOLISM	INHBA FFAR4	7.49e-03	88	21	2	M27211
Pubmed	Weak activity of UDP-glucuronosyltransferase toward Bisphenol analogs in mouse perinatal development.	UGT2B11 UGT2B10 UGT2B28	7.68e-09	7	22	3	26074487
Pubmed	Hetero-oligomer formation of mouse UDP-glucuronosyltransferase (UGT) 2b1 and 1a1 results in the gain of glucuronidation activity towards morphine, an activity which is absent in homo-oligomers of either UGT.	UGT2B11 UGT2B10 UGT2B28	1.23e-08	8	22	3	32093886
Pubmed	Modulation of activin signal transduction by inhibin B and inhibin-binding protein (INhBP).	INHBA BMPR1A BMPR1B	2.63e-08	10	22	3	11266516
Pubmed	The repertoire of solute carriers of family 6: identification of new human and rodent genes.	SLC6A8 SLC6A12 SLC6A13	2.90e-07	21	22	3	16125675
Pubmed	BMPR1A and BMPR1B Missense Mutations Cause Primary Ovarian Insufficiency.	BMPR1A BMPR1B	3.82e-07	2	22	2	31769494
Pubmed	M2-phenotype tumour-associated macrophages upregulate the expression of prognostic predictors MMP14 and INHBA in pancreatic cancer.	MMP14 INHBA	3.82e-07	2	22	2	35150061
Pubmed	Quantitative analysis of UGT2B28 mRNA expression by real-time RT-PCR and application to human tissue distribution study.	UGT2B11 UGT2B28	3.82e-07	2	22	2	21679149
Pubmed	Epithelial Bmpr1a regulates differentiation and proliferation in postnatal hair follicles and is essential for tooth development.	BMPR1A BMPR1B	3.82e-07	2	22	2	15102710
Pubmed	BMPR1A is necessary for chondrogenesis and osteogenesis, whereas BMPR1B prevents hypertrophic differentiation.	BMPR1A BMPR1B	3.82e-07	2	22	2	32764110
Pubmed	Assignment of the BMPR1A and BMPR1B genes to human chromosome 10q22.3 and 4q23-->q24 byin situ hybridization and radiation hybrid map ping.	BMPR1A BMPR1B	3.82e-07	2	22	2	9730621
Pubmed	[BMP7 signaling via BMPR1A, BMPR1B inhibits the proliferation of lung large carcinoma NCI-H460 cell].	BMPR1A BMPR1B	3.82e-07	2	22	2	20673479
Pubmed	Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates with tumor grade in human prostate cancer tissues.	BMPR1A BMPR1B	3.82e-07	2	22	2	10850425
Pubmed	Differential molecular regulation of processing and membrane expression of Type-I BMP receptors: implications for signaling.	BMPR1A BMPR1B	3.82e-07	2	22	2	28357470
Pubmed	Distinct roles of BMP receptors Type IA and IB in osteo-/chondrogenic differentiation in mesenchymal progenitors (C3H10T1/2).	BMPR1A BMPR1B	3.82e-07	2	22	2	15322331
Pubmed	The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways.	BMPR1A BMPR1B	1.15e-06	3	22	2	11714695
Pubmed	Transdifferentiation of alveolar epithelial type II to type I cells is controlled by opposing TGF-β and BMP signaling.	BMPR1A BMPR1B	1.15e-06	3	22	2	23831617
Pubmed	The type I BMP receptor ACVR1/ALK2 is required for chondrogenesis during development.	BMPR1A BMPR1B	1.15e-06	3	22	2	25413979
Pubmed	Neurotransmitter transporter family including SLC6A6 and SLC6A13 contributes to the 5-aminolevulinic acid (ALA)-induced accumulation of protoporphyrin IX and photodamage, through uptake of ALA by cancerous cells.	SLC6A8 SLC6A13	1.15e-06	3	22	2	24842606
Pubmed	Role of type I receptors for anti-Müllerian hormone in the SMAT-1 Sertoli cell line.	BMPR1A BMPR1B	1.15e-06	3	22	2	15897891
Pubmed	Granulosa cell-expressed BMPR1A and BMPR1B have unique functions in regulating fertility but act redundantly to suppress ovarian tumor development.	BMPR1A BMPR1B	1.15e-06	3	22	2	20363875
Pubmed	The transforming growth factor-beta type III receptor mediates distinct subcellular trafficking and downstream signaling of activin-like kinase (ALK)3 and ALK6 receptors.	BMPR1A BMPR1B	1.15e-06	3	22	2	19726563
Pubmed	Brd4 regulates NLRC4 inflammasome activation by facilitating IRF8-mediated transcription of Naips.	IRF8 NLRC4	1.15e-06	3	22	2	33535228
Pubmed	Astrocytic γ-aminobutyric acid (GABA) transporters mediate guanidinoacetate transport in rat brain.	SLC6A12 SLC6A13	1.15e-06	3	22	2	29175673
Pubmed	Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans.	BMPR1A BMPR1B	1.15e-06	3	22	2	26584636
Pubmed	Age-Associated Increase in BMP Signaling Inhibits Hippocampal Neurogenesis.	BMPR1A BMPR1B	1.15e-06	3	22	2	25538007
Pubmed	BMP signaling specifies the development of a large and fast CNS synapse.	BMPR1A BMPR1B	1.15e-06	3	22	2	23708139
Pubmed	Dendrite complexity of sympathetic neurons is controlled during postnatal development by BMP signaling.	BMPR1A BMPR1B	1.15e-06	3	22	2	24048844
Pubmed	Distinct developmental programs require different levels of Bmp signaling during mouse retinal development.	BMPR1A BMPR1B	1.15e-06	3	22	2	15673568
Pubmed	Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis.	BMPR1A BMPR1B	1.15e-06	3	22	2	7750489
Pubmed	Expression of bone morphogenetic protein receptors in the developing mouse metanephros.	BMPR1A BMPR1B	1.15e-06	3	22	2	11701996
Pubmed	BMPR1a and BMPR1b signaling exert opposing effects on gliosis after spinal cord injury.	BMPR1A BMPR1B	1.15e-06	3	22	2	20130193
Pubmed	cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily.	UGT2B11 UGT2B10	1.15e-06	3	22	2	8333863
Pubmed	Expression patterns of BMPRs in the developing mouse molar.	BMPR1A BMPR1B	1.15e-06	3	22	2	16432712
Pubmed	Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours.	BMPR1A BMPR1B	1.15e-06	3	22	2	8605097
Pubmed	Analysis of the native murine bone morphogenetic protein serine threonine kinase type I receptor (ALK-3).	BMPR1A BMPR1B	1.15e-06	3	22	2	8707881
Pubmed	Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation.	BMPR1A BMPR1B	1.15e-06	3	22	2	8592941
Pubmed	Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction.	BMPR1A BMPR1B	2.29e-06	4	22	2	11282024
Pubmed	Bone morphogenetic protein 4 (BMP4) signaling in retinoblastoma cells.	BMPR1A BMPR1B	2.29e-06	4	22	2	21152263
Pubmed	Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients.	BMPR1A BMPR1B	2.29e-06	4	22	2	20587070
Pubmed	Oligomeric interactions of TGF-β and BMP receptors.	BMPR1A BMPR1B	2.29e-06	4	22	2	22293501
Pubmed	Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors.	BMPR1A BMPR1B	2.29e-06	4	22	2	10712517
Pubmed	The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations.	BMPR1A BMPR1B	2.29e-06	4	22	2	15235019
Pubmed	A GDF5 point mutation strikes twice--causing BDA1 and SYNS2.	BMPR1A BMPR1B	2.29e-06	4	22	2	24098149
Pubmed	The protein kinase LKB1 negatively regulates bone morphogenetic protein receptor signaling.	BMPR1A BMPR1B	2.29e-06	4	22	2	26701726
Pubmed	Bone morphogenetic proteins, eye patterning, and retinocollicular map formation in the mouse.	BMPR1A BMPR1B	2.29e-06	4	22	2	18614674
Pubmed	Common genetic variants of the BMP4, BMPR1A, BMPR1B, and ACVR1 genes, left ventricular mass, and other parameters of the heart in newborns.	BMPR1A BMPR1B	2.29e-06	4	22	2	22971142
Pubmed	The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding.	INHBA BMPR1A	2.29e-06	4	22	2	16198295
Pubmed	Duplications involving a conserved regulatory element downstream of BMP2 are associated with brachydactyly type A2.	BMPR1A BMPR1B	2.29e-06	4	22	2	19327734
Pubmed	Effect of bone morphogenetic protein-6 on haemopoietic stem cells and cytokine production in normal human bone marrow stroma.	BMPR1A BMPR1B	2.29e-06	4	22	2	11401330
Pubmed	HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression.	BMPR1A BMPR1B	2.29e-06	4	22	2	24904118
Pubmed	LTP of inhibition at PV interneuron output synapses requires developmental BMP signaling.	BMPR1A BMPR1B	2.29e-06	4	22	2	32572071
Pubmed	Chromosomal localization of three human genes encoding bone morphogenetic protein receptors.	BMPR1A BMPR1B	2.29e-06	4	22	2	10051328
Pubmed	Mutations in the BMP pathway in mice support the existence of two molecular classes of holoprosencephaly.	BMPR1A BMPR1B	2.29e-06	4	22	2	17913790
Pubmed	Vascular smooth muscle cells express multiple type I receptors for TGF-beta, activin, and bone morphogenetic proteins.	BMPR1A BMPR1B	2.29e-06	4	22	2	8605036
Pubmed	Molecular characterization of four pharmacologically distinct gamma-aminobutyric acid transporters in mouse brain [corrected].	SLC6A12 SLC6A13	2.29e-06	4	22	2	8420981
Pubmed	Embryonic and postnatal expression of four gamma-aminobutyric acid transporter mRNAs in the mouse brain and leptomeninges.	SLC6A12 SLC6A13	3.82e-06	5	22	2	8956109
Pubmed	Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2.	BMPR1A BMPR1B	3.82e-06	5	22	2	16127465
Pubmed	Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity.	INHBA BMPR1A	3.82e-06	5	22	2	8397373
Pubmed	Deletion of BMP receptor type IB decreased bone mass in association with compromised osteoblastic differentiation of bone marrow mesenchymal progenitors.	BMPR1A BMPR1B	3.82e-06	5	22	2	27048979
Pubmed	Mechanisms of bone morphogenetic protein 2 (BMP2) stimulated inhibitor of DNA binding 3 (Id3) transcription.	BMPR1A BMPR1B	3.82e-06	5	22	2	21056086
Pubmed	Bone morphogenetic proteins and growth and differentiation factors in the human cornea.	BMPR1A BMPR1B	3.82e-06	5	22	2	9950587
Pubmed	Expression of bone morphogenetic proteins 4 and 7 and their receptors IA, IB, and II in human ovaries from fetuses and adults.	BMPR1A BMPR1B	3.82e-06	5	22	2	17624341
Pubmed	Restriction of Legionella pneumophila replication in macrophages requires concerted action of the transcriptional regulators Irf1 and Irf8 and nod-like receptors Naip5 and Nlrc4.	IRF8 NLRC4	3.82e-06	5	22	2	19720760
Pubmed	Crystal structure analysis reveals a spring-loaded latch as molecular mechanism for GDF-5-type I receptor specificity.	BMPR1A BMPR1B	3.82e-06	5	22	2	19229295
Pubmed	Cartilage-derived morphogenetic proteins and osteogenic protein-1 differentially regulate osteogenesis.	BMPR1A BMPR1B	3.82e-06	5	22	2	9525338
Pubmed	Mutual regulation of follicle-stimulating hormone signaling and bone morphogenetic protein system in human granulosa cells.	BMPR1A BMPR1B	3.82e-06	5	22	2	16436528
Pubmed	Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor.	BMPR1A BMPR1B	3.82e-06	5	22	2	18184661
Pubmed	Deletion of the γ-aminobutyric acid transporter 2 (GAT2 and SLC6A13) gene in mice leads to changes in liver and brain taurine contents.	SLC6A12 SLC6A13	3.82e-06	5	22	2	22896705
Pubmed	Role of BMP Signaling for the Formation of Auditory Brainstem Nuclei and Large Auditory Relay Synapses.	BMPR1A BMPR1B	3.82e-06	5	22	2	30548566
Pubmed	Bone morphogenetic protein receptor type II is a receptor for growth differentiation factor-9.	BMPR1A BMPR1B	3.82e-06	5	22	2	12135884
Pubmed	Expression of Fgf and Tgfbeta signaling related genes during embryonic endochondral ossification.	INHBA BMPR1A BMPR1B	4.49e-06	51	22	3	15963767
Pubmed	TGFbeta superfamily signals are required for morphogenesis of the kidney mesenchyme progenitor population.	INHBA BMPR1A BMPR1B	5.64e-06	55	22	3	15342483
Pubmed	BMP-Smad4 signaling is required for precartilaginous mesenchymal condensation independent of Sox9 in the mouse.	BMPR1A BMPR1B	5.72e-06	6	22	2	25641697
Pubmed	Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression.	BMPR1A BMPR1B	5.72e-06	6	22	2	16604073
Pubmed	Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4.	BMPR1A BMPR1B	5.72e-06	6	22	2	8006002
Pubmed	BMP signaling plays a role in visceral endoderm differentiation and cavitation in the early mouse embryo.	BMPR1A BMPR1B	5.72e-06	6	22	2	9876182
Pubmed	Mesenchymal factor bone morphogenetic protein 4 restricts ductal budding and branching morphogenesis in the developing prostate.	BMPR1A BMPR1B	5.72e-06	6	22	2	11401393
Pubmed	BMP/SMAD signaling regulates the cell behaviors that drive the initial dorsal-specific regional morphogenesis of the otocyst.	BMPR1A BMPR1B	5.72e-06	6	22	2	20837004
Pubmed	BMP type I receptor complexes have distinct activities mediating cell fate and axon guidance decisions.	BMPR1A BMPR1B	5.72e-06	6	22	2	18272594
Pubmed	Type I receptor binding of bone morphogenetic protein 6 is dependent on N-glycosylation of the ligand.	BMPR1A BMPR1B	8.01e-06	7	22	2	18070108
Pubmed	Molecular recognition of BMP-2 and BMP receptor IA.	BMPR1A BMPR1B	8.01e-06	7	22	2	15064755
Pubmed	SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.	BMPR1A BMPR1B	8.01e-06	7	22	2	12065756
Pubmed	Differential effects of BMP signaling on parvalbumin and somatostatin interneuron differentiation.	BMPR1A BMPR1B	8.01e-06	7	22	2	19592576
Pubmed	BMP and BMP receptor expression during murine organogenesis.	BMPR1A BMPR1B	8.01e-06	7	22	2	19393343
Pubmed	Differential expression of BMP receptors in early mouse development.	BMPR1A BMPR1B	8.01e-06	7	22	2	9303341
Pubmed	Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse ureter.	BMPR1A BMPR1B	8.01e-06	7	22	2	10749566
Pubmed	Expression and misexpression of members of the FGF and TGFbeta families of growth factors in the developing mouse pancreas.	INHBA BMPR1A BMPR1B	9.80e-06	66	22	3	12666204
Pubmed	DRAGON, a bone morphogenetic protein co-receptor.	BMPR1A BMPR1B	1.07e-05	8	22	2	15671031
Pubmed	Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5.	BMPR1A BMPR1B	1.07e-05	8	22	2	8702914
Pubmed	Identification of receptors and signaling pathways for orphan bone morphogenetic protein/growth differentiation factor ligands based on genomic analyses.	BMPR1A BMPR1B	1.07e-05	8	22	2	16049014
Pubmed	HOXA13 regulates the expression of bone morphogenetic proteins 2 and 7 to control distal limb morphogenesis.	BMPR1A BMPR1B	1.07e-05	8	22	2	15342482
Pubmed	Type Ib BMP receptors mediate the rate of commissural axon extension through inhibition of cofilin activity.	BMPR1A BMPR1B	1.07e-05	8	22	2	23250207
Pubmed	Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation.	BMPR1A BMPR1B	1.07e-05	8	22	2	10504300
Pubmed	Combinatorial signaling through BMP receptor IB and GDF5: shaping of the distal mouse limb and the genetics of distal limb diversity.	BMPR1A BMPR1B	1.07e-05	8	22	2	10631181
Pubmed	BmpR1A is a major type 1 BMP receptor for BMP-Smad signaling during skull development.	BMPR1A BMPR1B	1.37e-05	9	22	2	28641928
Pubmed	Mutant GDF5 enhances ameloblast differentiation via accelerated BMP2-induced Smad1/5/8 phosphorylation.	BMPR1A BMPR1B	1.37e-05	9	22	2	27030100
Pubmed	Irf8-regulated genomic responses drive pathological inflammation during cerebral malaria.	IRF8 NLRC4	1.37e-05	9	22	2	23853600
Pubmed	New insights into the molecular mechanism of multiple synostoses syndrome (SYNS): mutation within the GDF5 knuckle epitope causes noggin-resistance.	BMPR1A BMPR1B	1.37e-05	9	22	2	21976273
Pubmed	Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads.	BMPR1A BMPR1B	1.37e-05	9	22	2	12857866
Pubmed	Bone morphogenetic protein 6-induced interleukin-1β expression in macrophages requires PU.1/Smad1 interaction.	BMPR1A BMPR1B	1.71e-05	10	22	2	21571370
Interaction	UGT2B28 interactions	UGT2B11 UGT2B10 UGT2B28	1.95e-08	6	21	3	int:UGT2B28
Interaction	IGSF1 interactions	INHBA BMPR1A BMPR1B	4.40e-07	15	21	3	int:IGSF1
Interaction	UGT2B10 interactions	UGT2B10 UGT2B28	1.03e-05	5	21	2	int:UGT2B10
Interaction	GDF6 interactions	BMPR1A BMPR1B	2.16e-05	7	21	2	int:GDF6
Interaction	UGT2B11 interactions	UGT2B11 UGT2B28	2.16e-05	7	21	2	int:UGT2B11
Interaction	RGMB interactions	BMPR1A BMPR1B	2.88e-05	8	21	2	int:RGMB
Interaction	BAMBI interactions	BMPR1A BMPR1B	1.08e-04	15	21	2	int:BAMBI
Interaction	PRKD2 interactions	UGT2B11 UGT2B10 ATG16L1 UGT2B28	1.25e-04	254	21	4	int:PRKD2
Interaction	PEG10 interactions	IMMP2L BMPR1A BMPR1B	1.76e-04	106	21	3	int:PEG10
Interaction	BMPR2 interactions	INHBA BMPR1A BMPR1B	1.96e-04	110	21	3	int:BMPR2
Interaction	BMP6 interactions	BMPR1A BMPR1B	2.15e-04	21	21	2	int:BMP6
Cytoband	4q13.2	UGT2B11 UGT2B10 UGT2B28	4.26e-07	31	22	3	4q13.2
Cytoband	Ensembl 112 genes in cytogenetic band chr4q13	UGT2B11 UGT2B10 UGT2B28	5.76e-05	157	22	3	chr4q13
Cytoband	Ensembl 112 genes in cytogenetic band chr10q23	BMPR1A FFAR4	3.92e-03	195	22	2	chr10q23
Cytoband	Ensembl 112 genes in cytogenetic band chr12p13	SLC6A12 SLC6A13	1.23e-02	353	22	2	chr12p13
GeneFamily	UDP glucuronosyltransferases	UGT2B11 UGT2B10 UGT2B28	3.37e-06	32	17	3	363
GeneFamily	Type 1 receptor serine/threonine kinases	BMPR1A BMPR1B	1.74e-05	7	17	2	345
GeneFamily	Solute carriers	SLC6A8 SLC6A12 SLC6A13	5.60e-03	395	17	3	752
GeneFamily	WD repeat domain containing	ATG16L1 TBL2	2.47e-02	262	17	2	362
Coexpression	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4	UGT2B11 UGT2B10 IMMP2L SLC6A12 UGT2B28	6.78e-06	330	22	5	MM1120
Coexpression	WENG_POR_TARGETS_LIVER_UP	UGT2B11 UGT2B10 UGT2B28	1.17e-05	53	22	3	MM1203
Coexpression	GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_UP	IRF8 MMP14 SLC6A8 INHBA	2.16e-05	200	22	4	M3962
Coexpression	ZAMORA_NOS2_TARGETS_DN	SLC6A8 SLC6A13 UGT2B28	4.35e-05	82	22	3	M1638
Coexpression	GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_UP	MMP14 INHBA SLC6A12 BMPR1B	5.75e-05	257	22	4	M41025
Coexpression	VANLOO_SP3_TARGETS_DN	UGT2B11 UGT2B10 UGT2B28	8.60e-05	103	22	3	MM919
Coexpression	SERVITJA_ISLET_HNF1A_TARGETS_DN	UGT2B11 UGT2B10 UGT2B28	1.39e-04	121	22	3	MM935
Coexpression	HALLMARK_UV_RESPONSE_UP	MMP14 SLC6A8 SLC6A12	3.04e-04	158	22	3	M5941
Coexpression	GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN	MMP14 INHBA SLC6A12	4.24e-04	177	22	3	M7637
Coexpression	SERVITJA_LIVER_HNF1A_TARGETS_DN	UGT2B11 UGT2B10 UGT2B28	5.22e-04	190	22	3	MM1311
Coexpression	GSE6259_BCELL_VS_CD8_TCELL_UP	MMP14 BMPR1A STON1	5.46e-04	193	22	3	M6735
Coexpression	BOCHKIS_FOXA2_TARGETS	UGT2B11 UGT2B10 SLC6A12 UGT2B28	5.64e-04	467	22	4	MM1233
Coexpression	HEVNER_CORTEX_ROSTRAL_CORTICAL_PLATE	INHBA BMPR1B	5.67e-04	42	22	2	MM446
Coexpression	GSE17721_CTRL_VS_LPS_8H_BMDC_DN	IRF8 MMP14 BMPR1A	5.97e-04	199	22	3	M3700
Coexpression	GSE17721_0.5H_VS_8H_LPS_BMDC_DN	IRF8 MMP14 BMPR1A	5.97e-04	199	22	3	M4075
Coexpression	GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP	MMP14 BMPR1A STON1	5.97e-04	199	22	3	M7448
Coexpression	GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN	IRF8 TBL2 BMPR1A	5.97e-04	199	22	3	M6987
Coexpression	GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_DN	SLC6A12 SLC6A13 TTC14	6.06e-04	200	22	3	M9067
Coexpression	GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_UP	FFAR4 STON1 TTC14	6.06e-04	200	22	3	M6363
Coexpression	GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP	UGT2B10 INHBA APH1B	6.06e-04	200	22	3	M9391
Coexpression	GSE17721_0.5H_VS_4H_LPS_BMDC_DN	MMP14 SLC6A13 BMPR1A	6.06e-04	200	22	3	M4073
Coexpression	GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_UP	SLC6A12 SLC6A13 BMPR1A	6.06e-04	200	22	3	M385
Coexpression	GSE17721_CTRL_VS_LPS_4H_BMDC_DN	MMP14 SLC6A13 BMPR1A	6.06e-04	200	22	3	M3690
Coexpression	GSE27786_CD4_TCELL_VS_MONO_MAC_DN	SLC6A12 STAG2 BMPR1A	6.06e-04	200	22	3	M4834
Coexpression	GSE36078_WT_VS_IL1R_KO_LUNG_DC_UP	MMP14 INHBA FFAR4	6.06e-04	200	22	3	M9299
Coexpression	GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_DN	UGT2B10 STAG2 BMPR1B	6.06e-04	200	22	3	M9657
Coexpression	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	MMP14 SLC6A8 INHBA	6.06e-04	200	22	3	M5930
Coexpression	GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_UP	UGT2B10 SLC6A8 SLC6A13	6.06e-04	200	22	3	M8201
Coexpression	OHGUCHI_LIVER_HNF4A_TARGETS_DN	UGT2B11 UGT2B10 UGT2B28	6.14e-04	201	22	3	MM1294
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IRF8 INHBA NLRC4 FFAR4	1.27e-06	167	22	4	881f64db8dea3faa7588bf04d87c20924a4e5952
ToppCell	Bronchial_Biopsy-Immune-Luminal_Macrophages\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	IRF8 INHBA NLRC4 FFAR4	1.53e-06	175	22	4	1cf99de391552d4f8dbe2ed5b01fc3b8adca61b6
ToppCell	Bronchial_Brush-Immune-Luminal_Macrophages\|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	IRF8 INHBA NLRC4 FFAR4	2.17e-06	191	22	4	88cb6f828407845918c946f8cee5f940cb81800a
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IRF8 INHBA NLRC4 FFAR4	2.50e-06	198	22	4	e125eb8aa57c172e5518874da1bd25998292f5e2
ToppCell	proximal-Hematologic-Alveolar_Macrophage-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	IRF8 INHBA NLRC4 FFAR4	2.50e-06	198	22	4	a5deecd8809bc5b38ffda02143598ad0145e2559
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IRF8 INHBA NLRC4 FFAR4	2.50e-06	198	22	4	0baeb8e2c199ff10bb5c829c523546af3c9227c1
ToppCell	proximal-Hematologic-Alveolar_Macrophage\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	IRF8 INHBA NLRC4 FFAR4	2.50e-06	198	22	4	ec0092ef6207e788e2c20ddf007a2f6f6e351d0b
ToppCell	proximal-3-Hematologic-Alveolar_Macrophage\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	IRF8 INHBA NLRC4 FFAR4	2.50e-06	198	22	4	a5daf11bf7fe614be9f4a0fc6a4b37b5dce2f6fc
ToppCell	Parenchymal-NucSeq-Immune_Myeloid\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IRF8 INHBA NLRC4 FFAR4	2.55e-06	199	22	4	7ee2805fd9143eba11bf6832267b62189683608b
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IRF8 INHBA NLRC4 FFAR4	2.60e-06	200	22	4	6e50272d172b491200d9a255ed08e6d6998cfe02
ToppCell	Lung_Parenchyma-Severe-Myeloid-TRAM-TRAM\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	IRF8 INHBA NLRC4 FFAR4	2.60e-06	200	22	4	196dd7a90f6f334496997af0375e7a2c86f9a197
ToppCell	Lung_Parenchyma-Severe-Myeloid-TRAM\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	IRF8 INHBA NLRC4 FFAR4	2.60e-06	200	22	4	5e6f965f7b1323f1309543f44335d519996dfc1e
ToppCell	Lung_Parenchyma-Severe-Myeloid-TRAM-TRAM-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IRF8 INHBA NLRC4 FFAR4	2.60e-06	200	22	4	18f1415cfc718beffd91fb9f643cced2eefbca8d
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IRF8 INHBA NLRC4 FFAR4	2.60e-06	200	22	4	840be665639a53ba9bafc19f7a81ca1e0436e329
ToppCell	E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT1_Precursor\|E16.5-samps / Age Group, Lineage, Cell class and subclass	SLC6A12 SLC6A13 FFAR4	5.77e-05	154	22	3	8a643d91896af9b630a715fb284c1523d01ad1a3
ToppCell	PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IRF8 SLC6A13 FFAR4	6.00e-05	156	22	3	af47a4b17342bdb3cb62d7e2d52a81168e588629
ToppCell	frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MMP14 SLC6A12 SLC6A13	6.35e-05	159	22	3	34c90711c5857cf6ada7b3acff99f1d48c7caf29
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF8 SLC6A8 TRIM15	6.71e-05	162	22	3	22f1abd20f43bc7e7fc46969da9962faf70ae5d2
ToppCell	facs-Lung-Endomucin_-18m-Lymphocytic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF8 IMMP2L SLC6A13	6.71e-05	162	22	3	e81dec1db8e5a808d96e58410c91961e5d065c94
ToppCell	facs-Lung-Endomucin_-18m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF8 IMMP2L SLC6A13	6.71e-05	162	22	3	d19b469f64c9064cfb82dadb6c8135e28949a02a
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF8 SLC6A8 TRIM15	6.71e-05	162	22	3	966df4558140c3d541999ab553f201ae76a1c401
ToppCell	facs-Lung-Endomucin_-18m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF8 IMMP2L SLC6A13	6.71e-05	162	22	3	10c2aa047f33f48e4abe676236bbdb593079dd1d
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_4\|356C / Donor, Lineage, Cell class and subclass (all cells)	NLRC4 FFAR4 STON1	6.71e-05	162	22	3	7d43d59531cbefe3ac94953b7faf7156b2a31441
ToppCell	Sigmoid-Macrophage-Macrophage\|Macrophage / Region, Cell class and subclass	IRF8 MMP14 TTC14	7.48e-05	168	22	3	bb16e135b6ae0d66615420b61edd6f62f2a3233c
ToppCell	356C-Epithelial_cells-Epithelial-D_(AT2)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	INHBA NLRC4 FFAR4	7.61e-05	169	22	3	f982f2e0d341fa27229f443ebe5c0e4a9e63bda6
ToppCell	356C-Epithelial_cells-Epithelial-D_(AT2)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	INHBA NLRC4 FFAR4	7.61e-05	169	22	3	818ab7a6fd1940a22d3bd99fe15f0af888af6b3e
ToppCell	frontal_cortex-Non-neuronal-leptomeningeal_cell\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MMP14 SLC6A12 SLC6A13	7.88e-05	171	22	3	2e43fb129ee9bdc3b31febc43c10f959bf0f4a7d
ToppCell	frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MMP14 SLC6A12 SLC6A13	7.88e-05	171	22	3	e219a1aa59a96e4bc3e2eacf985679174a51de41
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IRF8 INHBA FFAR4	8.01e-05	172	22	3	c8ea80042faf923b08ff03d73100533d521d73ef
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-Alveolar_Mac\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	INHBA SLC6A12 FFAR4	8.15e-05	173	22	3	4efa0878ed1ede8fa5d6c191a76d4f70558ba761
ToppCell	Macrophages-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	INHBA FFAR4 STON1	8.15e-05	173	22	3	a112da5b0ab6e1f13d1a7dfa72c67c9a95fa9243
ToppCell	primary_visual_cortex-Non-neuronal-leptomeningeal_cell\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MMP14 SLC6A12 SLC6A13	8.29e-05	174	22	3	2891ab2fd05eb4bbd239d1a2865f21ef7f2df39e
ToppCell	primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MMP14 SLC6A12 SLC6A13	8.29e-05	174	22	3	eade55f86ef1f7a5355ad65cec3aa6bfc5d3c62d
ToppCell	3'_v3-blood-Mast-Mast_cells\|blood / Manually curated celltypes from each tissue	UGT2B11 MMP14 ACCS	8.58e-05	176	22	3	b9da3deaf62622d47eb30b6be7548253eee95597
ToppCell	primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MMP14 SLC6A12 SLC6A13	8.72e-05	177	22	3	599cf7f5b774e197a1b43c98e4b9a8c1a618f38a
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	INHBA NLRC4 FFAR4	8.87e-05	178	22	3	0b398656f26c4061b11ccf98908d0e2e1367585a
ToppCell	facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IRF8 APH1B FFAR4	9.02e-05	179	22	3	33ed9270d257895ff3b40df2c1af878119c9f492
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	IRF8 MMP14 SLC6A8	9.94e-05	185	22	3	7bff05d8d34616adbaa0ea0b69eb30aa906bb9f8
ToppCell	droplet-Fat-SCAT-30m-Epithelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INHBA TBL2 BMPR1B	1.03e-04	187	22	3	5fada3c5a58c1890029ccbfff2608b33f8cd2df7
ToppCell	droplet-Fat-SCAT-30m-Epithelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INHBA TBL2 BMPR1B	1.03e-04	187	22	3	766e808138fc2cd623c2e6d57fcb5c7378da0e03
ToppCell	droplet-Fat-SCAT-30m-Epithelial-epithelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INHBA TBL2 BMPR1B	1.03e-04	187	22	3	f49d06600060deeb2fc1b1da5b93496535f20104
ToppCell	Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	IRF8 INHBA FFAR4	1.04e-04	188	22	3	d7a9fb5b021e127b8d927658a55a71098d513b5c
ToppCell	390C-Myeloid-Macrophage-FABP4+_Macrophage_2\|390C / Donor, Lineage, Cell class and subclass (all cells)	INHBA NLRC4 FFAR4	1.06e-04	189	22	3	3b5e1a8d5c1e1fa2124f64f212e9c6b8f1b7d7da
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_2\|356C / Donor, Lineage, Cell class and subclass (all cells)	INHBA FFAR4 STON1	1.08e-04	190	22	3	4cce4ddb79b7751d0103e10f71156977e0c34439
ToppCell	343B-Myeloid-Macrophage-FABP4+_Macrophage_2\|343B / Donor, Lineage, Cell class and subclass (all cells)	INHBA NLRC4 FFAR4	1.08e-04	190	22	3	6514f00d222eef08c282face7f177259bca62f0e
ToppCell	390C-Myeloid-Macrophage\|390C / Donor, Lineage, Cell class and subclass (all cells)	INHBA NLRC4 FFAR4	1.08e-04	190	22	3	f933d971f092c4e56e9f670a9205b688c8b1ca28
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IRF8 INHBA FFAR4	1.09e-04	191	22	3	723dc09607e791e9517a22c6482d6cd6b07ce1d6
ToppCell	COVID-19-lung-Macrophage_PPARGhi_CD5Lhi\|lung / Disease (COVID-19 only), tissue and cell type	IRF8 INHBA FFAR4	1.09e-04	191	22	3	dab953682b8c9ed680a799161f837f792a7e4f33
ToppCell	COVID-19-lung-Macrophage_PPARGhi_CD5Lhi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	IRF8 INHBA FFAR4	1.11e-04	192	22	3	bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff
ToppCell	NS-moderate-d_0-4-Myeloid-Resident_Macrophage\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	IRF8 SLC6A12 NLRC4	1.13e-04	193	22	3	e530d4349b257f2590c799bf082ed6318700c526
ToppCell	Macrophages-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	INHBA FFAR4 STON1	1.13e-04	193	22	3	a6694b33adcdb17cdd1567eb9507dbf06e6468d8
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage\|367C / Donor, Lineage, Cell class and subclass (all cells)	INHBA NLRC4 FFAR4	1.14e-04	194	22	3	40c91ed945bd5990a0dbf2090d37a660b19aaab2
ToppCell	Macrophages-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	INHBA FFAR4 STON1	1.14e-04	194	22	3	543b856b0fd883550c8f14baeae08fb9bf1a7768
ToppCell	390C-Myeloid-Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	MMP14 INHBA FFAR4	1.16e-04	195	22	3	ba494be431916d43c1d480f65bed674c0722c710
ToppCell	normal_Lung-Epithelial_cells-Undetermined\|Epithelial_cells / Location, Cell class and cell subclass	IRF8 INHBA FFAR4	1.16e-04	195	22	3	31710a593d503e46acad1db38adacace4d863388
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	INHBA NLRC4 FFAR4	1.16e-04	195	22	3	c96755d2eb98112b703b5dbee9c88730ace7dcbf
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	INHBA FFAR4 STON1	1.16e-04	195	22	3	ec218ae03ebf8588996e86d6d9a8ea3cf71affaa
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM2\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	INHBA NLRC4 FFAR4	1.20e-04	197	22	3	d8ef5cb88dd66e112cb94217b9ad5cd70164f1d0
ToppCell	Severe_COVID-19-Myeloid-TRAM2\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	INHBA NLRC4 FFAR4	1.20e-04	197	22	3	8a126cfe1529f3d75a806aa492743314a8a43ef9
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	INHBA NLRC4 FFAR4	1.20e-04	197	22	3	33f2fe101ae5744eea3915add37e60aa398bb97f
ToppCell	Bronchus_Control_(B.)-Immune-TX-TRAM-2\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	IRF8 SLC6A12 NLRC4	1.20e-04	197	22	3	eecb693367510da20a6b1e9355e68785a1e3b85c
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	INHBA NLRC4 FFAR4	1.20e-04	197	22	3	9262785807faeb32417fad7ef202405053e453e2
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	INHBA NLRC4 FFAR4	1.20e-04	197	22	3	5e9a3932ae5147a3d73dc70f1545926a692930ed
ToppCell	NS-moderate-d_0-4-Myeloid\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	IRF8 SLC6A12 NLRC4	1.22e-04	198	22	3	1791f1b1195ac1735ca2c1e6adf04a7f39d63ac1
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MMP14 BMPR1A STON1	1.22e-04	198	22	3	bc9c9f2c87282b5ef8514773e065d2a6b5dde338
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)\|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MMP14 INHBA FFAR4	1.22e-04	198	22	3	ff9c97c6f579a4e79859d420f224556fadc1f6ab
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IRF8 INHBA FFAR4	1.23e-04	199	22	3	5b6feacb0ca92c3fc6b327be978320426dcf6f68
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IRF8 INHBA FFAR4	1.23e-04	199	22	3	fde8e3ba19d19069a4d3b8db55bfe6220cf634d5
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IRF8 INHBA FFAR4	1.23e-04	199	22	3	8e9862907b15809d083216e7d6a0f435015e5d15
ToppCell	Lung_Parenchyma-Control-Myeloid-TRAM-TRAM-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IRF8 INHBA FFAR4	1.25e-04	200	22	3	ec39df7fb4454af629a4a4f6755bd02c9581a2ca
ToppCell	Lung_Parenchyma-Control-Myeloid-TRAM\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IRF8 INHBA FFAR4	1.25e-04	200	22	3	ecd2b9a7d464792b77381d0a0bc7030e77ad3581
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IRF8 INHBA FFAR4	1.25e-04	200	22	3	a443e475e7a10c26a6173d1af961de6219e0e567
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IRF8 INHBA FFAR4	1.25e-04	200	22	3	ed785a6d08ca2b350dc3307b587eadfb2886d1f9
ToppCell	Lung_Parenchyma-Control-Myeloid-TRAM-TRAM\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IRF8 INHBA FFAR4	1.25e-04	200	22	3	b303553aca8fc021f932b52e88e9ef270d5a4f03
ToppCell	metastatic_Lymph_Node-Fibroblasts-Myofibroblasts\|Fibroblasts / Location, Cell class and cell subclass	MMP14 INHBA	5.87e-04	73	22	2	116259a036373bccaeb77fe3c675741a5ca81c52
ToppCell	(6)_Macrophage-(60)_Macrophage\|(6)_Macrophage / shred on Cell_type and subtype	IRF8 MMP14	6.03e-04	74	22	2	356978d2ee61e7042d7a9ad3bc744d3e7a7f76c0
ToppCell	Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Rbp4-Inhibitory_Neuron.Gad1Gad2_Sst.Rbp4_(Interneuron,_OLM2_(CA1_enriched?))\|Hippocampus / BrainAtlas - Mouse McCarroll V32	TRIM15 FFAR4	6.53e-04	77	22	2	9a29879348b32b6c2302820f75fd55efba39aae8
ToppCell	Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Rbp4\|Hippocampus / BrainAtlas - Mouse McCarroll V32	TRIM15 FFAR4	6.53e-04	77	22	2	3763b55e5ce44b844da661e9024c9f2c847ea26f
ToppCell	Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Rbp4-Inhibitory_Neuron.Gad1Gad2_Sst.Rbp4_(Interneuron,_OLM2_(CA1_enriched?))-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	TRIM15 FFAR4	6.53e-04	77	22	2	c5262a0d2040b2c580601e5a8d1ec626a0c7b560
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Signet-3\|TCGA-Stomach / Sample_Type by Project: Shred V9	UGT2B11 UGT2B28	7.40e-04	82	22	2	73ddc0286bea35f6d283cea30000a541cc6543c7
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)\|Thalamus / BrainAtlas - Mouse McCarroll V32	SLC6A12 SLC6A13	9.30e-04	92	22	2	bbaf5a131f860198840e34843b7c841bcc98d9c4
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-\|Thalamus / BrainAtlas - Mouse McCarroll V32	SLC6A12 SLC6A13	9.30e-04	92	22	2	e6aa2b8ca9235a7291ee41d976b886fec185835d
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	SLC6A12 SLC6A13	9.30e-04	92	22	2	926e02725a03d8473eda25d4aef63e34a6566224
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	SLC6A12 SLC6A13	9.30e-04	92	22	2	d2c1d25e5bb6ba4f406e916e3c0a5ad05492e59d
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	SLC6A12 SLC6A13	9.91e-04	95	22	2	3699ea16660a22ea79fecfea56ece2dfb0f13467
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	SLC6A12 SLC6A13	9.91e-04	95	22	2	cbfe615d880913bafaf5e7e8d24c3ec14a9351ce
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	SLC6A12 SLC6A13	9.91e-04	95	22	2	27ac23b87747434a3084cc087e7b884e68f0eab9
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_and_Lobular_Carcinoma-5\|TCGA-Breast / Sample_Type by Project: Shred V9	SLC6A13 TBL2	1.12e-03	101	22	2	f4db710b2510cdbee26dd5c3b581c85fe6f0be00
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	SLC6A12 SLC6A13	1.14e-03	102	22	2	0bbc6344d0baee47326a16a89773bb5c68a7b040
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	SLC6A12 SLC6A13	1.14e-03	102	22	2	11fbdb428824023603e9d4ee41e957ba84e7c29e
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	SLC6A12 SLC6A13	1.16e-03	103	22	2	39d8cfb899ca88c72ebe021d66cc21ae2eb6a1cc
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	SLC6A12 SLC6A13	1.16e-03	103	22	2	01a7baaa0c3903bd00e37717856d2c1ac21bf2c8
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2-Endothelial_Tip.Dcn.Ifitm1_(Ifitm1)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	SLC6A12 SLC6A13	1.25e-03	107	22	2	5356499561a62a80ecd7d9a260aea87bc70543fd
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	SLC6A12 SLC6A13	1.25e-03	107	22	2	8bdfb603ee0e8ca667847be016a9ee5f4f1712f8
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2-Endothelial_Tip.Dcn.Ifitm1_(Ifitm1)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	SLC6A12 SLC6A13	1.25e-03	107	22	2	7dda60d30c12d9ee15cda5fcbc75c317ca2d026f
ToppCell	primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Hs3st6\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SLC6A12 SLC6A13	1.25e-03	107	22	2	4a18261492371d19b8dbd403e197fdf64ef69392
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2-Endothelial_Tip.Dcn.Ifitm1_(Ifitm1)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	SLC6A12 SLC6A13	1.28e-03	108	22	2	2a00a9d3c9ef0c9c743939ee6e79ccbd401eccf7
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2-Endothelial_Tip.Dcn.Ifitm1_(Ifitm1)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	SLC6A12 SLC6A13	1.28e-03	108	22	2	db82e0273ce10627462ff0402f4c1d4c9cb3875b
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	SLC6A12 SLC6A13	1.28e-03	108	22	2	0c8bac6c520a3600765327c44705675927bc2f60
ToppCell	Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1\|Striatum / BrainAtlas - Mouse McCarroll V32	SLC6A12 SLC6A13	1.30e-03	109	22	2	f4b9fe5335cabe48a5fae7ec51bab0d7bdb17321
Drug	C1 11-32	UGT2B11 UGT2B10 UGT2B28	6.33e-07	18	22	3	CID000443077
Drug	C11131	UGT2B11 UGT2B10 UGT2B28	6.33e-07	18	22	3	CID000443076
Drug	T4-G	UGT2B11 UGT2B10 UGT2B28	7.51e-07	19	22	3	CID000152424
Drug	16-epiestriol	UGT2B11 UGT2B10 INHBA UGT2B28	8.44e-07	77	22	4	CID000003269
Drug	estriol-16-glucuronide	UGT2B11 UGT2B10 UGT2B28	1.03e-06	21	22	3	CID000122281
Drug	estradiol-3-glucuronide	UGT2B11 UGT2B10 UGT2B28	1.37e-06	23	22	3	CID000066651
Drug	L-idaro-1,4-lactone	UGT2B11 UGT2B10 UGT2B28	2.53e-06	28	22	3	CID000078997
Drug	7-hydroxycoumarin glucuronide	UGT2B11 UGT2B10 UGT2B28	2.81e-06	29	22	3	CID000125641
Drug	BP-3,6-quinol	UGT2B11 UGT2B10 UGT2B28	4.19e-06	33	22	3	CID000119292
Drug	AC1Q6OQG	UGT2B11 UGT2B10 UGT2B28	4.19e-06	33	22	3	CID000009686
Drug	fibrates	UGT2B11 UGT2B10 ACCS UGT2B28	4.67e-06	118	22	4	CID000002797
Drug	AC1NOWCJ	UGT2B11 UGT2B10 UGT2B28	5.02e-06	35	22	3	CID005120112
Drug	3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one	UGT2B11 UGT2B10 UGT2B28	5.02e-06	35	22	3	CID010436171
Drug	estrone-3-glucuronide	UGT2B11 UGT2B10 UGT2B28	5.02e-06	35	22	3	CID000115255
Drug	l-borneol	UGT2B11 UGT2B10 UGT2B28	5.96e-06	37	22	3	CID000010049
Drug	AC1L1FK5	UGT2B11 UGT2B10 INHBA UGT2B28	6.65e-06	129	22	4	CID000003272
Drug	harmol	UGT2B11 UGT2B10 UGT2B28	7.56e-06	40	22	3	CID000068094
Drug	2-AF	UGT2B11 UGT2B10 UGT2B28	8.15e-06	41	22	3	CID000005800
Drug	testosterone glucuronide	UGT2B11 UGT2B10 UGT2B28	8.15e-06	41	22	3	CID000108192
Drug	androsterone glucuronide	UGT2B11 UGT2B10 UGT2B28	9.42e-06	43	22	3	CID000114833
Drug	7,8-benzoquinoline	UGT2B11 UGT2B10 UGT2B28	9.42e-06	43	22	3	CID000009191
Drug	MS-222	UGT2B11 UGT2B10 UGT2B28	1.01e-05	44	22	3	CID000011400
Drug	salicylamide	UGT2B11 UGT2B10 UGT2B28	1.32e-05	48	22	3	CID000005147
Drug	AC1NQGK1	UGT2B11 UGT2B10 UGT2B28	1.68e-05	52	22	3	CID005195977
Drug	oxazepam	UGT2B11 UGT2B10 UGT2B28	1.78e-05	53	22	3	CID000004616
Drug	Pyrvinium pamoate [3546-41-6]; Up 200; 3.4uM; HL60; HT_HG-U133A	MMP14 INHBA SLC6A12 STON1	2.02e-05	171	22	4	2957_UP
Drug	7-methoxycoumarin	UGT2B11 UGT2B10 UGT2B28	2.21e-05	57	22	3	CID000010748
Drug	phenolphthalein	UGT2B11 UGT2B10 UGT2B28	2.33e-05	58	22	3	CID000004764
Drug	urochloralic acid	UGT2B11 UGT2B10 UGT2B28	2.46e-05	59	22	3	CID003036914
Drug	4-hydroxybiphenyl	UGT2B11 UGT2B10 UGT2B28	2.46e-05	59	22	3	CID000007103
Drug	4-hydroxyestrone	UGT2B11 UGT2B10 UGT2B28	2.46e-05	59	22	3	CID000018418
Drug	SN-38G	UGT2B11 UGT2B10 UGT2B28	2.46e-05	59	22	3	CID000443154
Drug	acetaminophen glucuronide	UGT2B11 UGT2B10 UGT2B28	2.46e-05	59	22	3	CID000083944
Drug	UDP-alpha-d-xylopyranose	UGT2B11 UGT2B10 UGT2B28	2.59e-05	60	22	3	CID000001165
Drug	3-OHBaP	UGT2B11 UGT2B10 UGT2B28	2.99e-05	63	22	3	CID000025890
Drug	Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; PC3; HT_HG-U133A	MMP14 SLC6A8 INHBA STON1	3.45e-05	196	22	4	2080_UP
Drug	Meldola	UGT2B11 UGT2B10 UGT2B28	3.77e-05	68	22	3	CID000081507
Drug	methoxyresorufin	UGT2B11 UGT2B10 UGT2B28	3.94e-05	69	22	3	CID000119220
Drug	2,2,2-trichloroethanol	UGT2B11 UGT2B10 UGT2B28	4.66e-05	73	22	3	CID000008259
Drug	eugenol	UGT2B11 UGT2B10 UGT2B28	4.66e-05	73	22	3	CID000003314
Drug	Aroclor 1254	UGT2B11 UGT2B10 TBL2 UGT2B28	4.77e-05	213	22	4	CID000040470
Drug	bornane	SLC6A12 SLC6A13	4.88e-05	11	22	2	CID000092108
Drug	7-hydroxycoumarin	UGT2B11 UGT2B10 UGT2B28	5.05e-05	75	22	3	CID005281426
Drug	AC1N8H7N	UGT2B11 UGT2B10 UGT2B28	5.68e-05	78	22	3	CID004318740
Drug	benzyloxyresorufin	UGT2B11 UGT2B10 UGT2B28	5.68e-05	78	22	3	CID000114982
Drug	acridine	UGT2B11 UGT2B10 UGT2B28	6.36e-05	81	22	3	CID000009215
Drug	5 alpha-androstane	UGT2B11 UGT2B10 UGT2B28	7.09e-05	84	22	3	CID000094144
Drug	7-ethoxycoumarin	UGT2B11 UGT2B10 UGT2B28	7.61e-05	86	22	3	CID000035703
Drug	pentoxyresorufin	UGT2B11 UGT2B10 UGT2B28	7.87e-05	87	22	3	CID000107683
Drug	menthol	UGT2B11 UGT2B10 UGT2B28	7.87e-05	87	22	3	CID000001254
Drug	alpha-D-glucose 1-phosphate 6-vanadate	INHBA BMPR1A BMPR1B	8.15e-05	88	22	3	CID005289552
Drug	AC1L9KTS	SLC6A8 STON1	9.29e-05	15	22	2	CID000447405
Drug	4-aminobiphenyl	UGT2B11 UGT2B10 UGT2B28	9.30e-05	92	22	3	CID000007102
Drug	p-nitroanisole	UGT2B11 UGT2B10 UGT2B28	9.30e-05	92	22	3	CID000007485
Drug	phenolate	UGT2B11 MMP14 UGT2B10 UGT2B28	9.45e-05	254	22	4	CID000000996
Drug	2-naphthol	UGT2B11 UGT2B10 UGT2B28	9.60e-05	93	22	3	CID000008663
Drug	ethoxyresorufin	UGT2B11 UGT2B10 UGT2B28	1.02e-04	95	22	3	CID000003294
Drug	DCNB	UGT2B11 UGT2B10 UGT2B28	1.02e-04	95	22	3	CID000007443
Drug	AC1NDQBC	BMPR1A BMPR1B	1.06e-04	16	22	2	CID004629889
Drug	DB04103	UGT2B11 UGT2B10 UGT2B28	1.09e-04	97	22	3	CID004469987
Drug	1-naphthol	UGT2B11 UGT2B10 UGT2B28	1.12e-04	98	22	3	CID000007005
Drug	acetaminophen	UGT2B11 UGT2B10 UGT2B28 STON1	1.20e-04	270	22	4	CID000001983
Drug	3-hydroxyandrostan-17-one	UGT2B11 UGT2B10 UGT2B28	1.26e-04	102	22	3	CID000000225
Drug	rutecarpine	BMPR1A BMPR1B	1.35e-04	18	22	2	ctd:C028632
Drug	chrysin	UGT2B11 UGT2B10 UGT2B28	1.42e-04	106	22	3	CID005281607
Drug	pheophytin	UGT2B11 UGT2B10 UGT2B28 STON1	1.45e-04	284	22	4	CID000000250
Drug	fluconazole	UGT2B11 UGT2B10 UGT2B28	1.46e-04	107	22	3	CID000003365
Drug	2-naphthylamine	UGT2B11 UGT2B10 UGT2B28	1.58e-04	110	22	3	CID000007057
Drug	lithocholic acid	UGT2B11 UGT2B10 UGT2B28	1.85e-04	116	22	3	CID000009903
Drug	ethoxyquin	UGT2B11 UGT2B10 UGT2B28	1.85e-04	116	22	3	CID000003293
Drug	4-chlorobenzoate	ACCS TBL2	1.85e-04	21	22	2	CID000006318
Drug	AC1Q7AUJ	UGT2B11 UGT2B10 UGT2B28	1.90e-04	117	22	3	CID000003303
Drug	alpha-naphthoflavone	UGT2B11 UGT2B10 UGT2B28	1.94e-04	118	22	3	CID000011790
Drug	benzphetamine	UGT2B11 UGT2B10 UGT2B28	1.99e-04	119	22	3	CID000002341
Drug	AC1L1K15	INHBA BMPR1A BMPR1B	2.04e-04	120	22	3	CID000005293
Drug	hexobarbital	UGT2B11 UGT2B10 UGT2B28	2.42e-04	127	22	3	CID000003608
Drug	4-methylumbelliferone	UGT2B11 UGT2B10 UGT2B28	2.71e-04	132	22	3	CID003364573
Drug	AC1NE3ZR	BMPR1A BMPR1B	2.86e-04	26	22	2	CID004636208
Drug	oltipraz	UGT2B11 UGT2B10 UGT2B28	3.02e-04	137	22	3	CID000047318
Drug	corrigendum	BMPR1A BMPR1B	3.08e-04	27	22	2	CID000194752
Drug	sulfapyridine	ACCS STAG2	3.08e-04	27	22	2	CID000005336
Drug	difenoconazole	BMPR1A BMPR1B	3.32e-04	28	22	2	CID000086173
Drug	aniline	UGT2B11 UGT2B10 UGT2B28	3.35e-04	142	22	3	CID000006115
Drug	butylated hydroxytoluene	UGT2B11 UGT2B10 UGT2B28	3.42e-04	143	22	3	CID000031404
Drug	2,4-diaminobutyric acid	SLC6A12 SLC6A13	3.56e-04	29	22	2	CID000000470
Drug	Alprostadil [745-65-3]; Up 200; 11.2uM; HL60; HT_HG-U133A	INHBA SLC6A12 SLC6A13	3.57e-04	145	22	3	2938_UP
Drug	2 E1	UGT2B11 UGT2B10 UGT2B28	3.57e-04	145	22	3	CID006102788
Drug	guvacine	SLC6A12 SLC6A13	3.81e-04	30	22	2	CID000003532
Drug	MW 1	IRF8 BMPR1A BMPR1B	4.01e-04	151	22	3	CID000073965
Drug	AGN 193109	BMPR1A BMPR1B	4.07e-04	31	22	2	CID000177238
Drug	3 at 1	BMPR1A BMPR1B	4.07e-04	31	22	2	CID000073188
Drug	hypotaurine	SLC6A12 SLC6A13	4.07e-04	31	22	2	CID000107812
Drug	polyhexamethyleneguanidine	MMP14 INHBA ATG16L1	4.17e-04	153	22	3	ctd:C060540
Drug	ahz	BMPR1A BMPR1B	4.34e-04	32	22	2	CID000656929
Drug	disulfiram	UGT2B11 UGT2B10 UGT2B28	4.58e-04	158	22	3	CID000003117
Drug	AC1LCF1F	UGT2B11 UGT2B10 UGT2B28	4.84e-04	161	22	3	CID000627275
Drug	tert-butyl glutaminate	SLC6A12 SLC6A13	4.91e-04	34	22	2	CID003450458
Drug	al-Badry	UGT2B11 UGT2B10 UGT2B28	5.20e-04	165	22	3	CID000004545
Drug	estrone-d4	UGT2B11 UGT2B10 UGT2B28	5.48e-04	168	22	3	CID000000698
Drug	titanium	MMP14 BMPR1A BMPR1B	5.67e-04	170	22	3	CID000023963
Disease	plasma clozapine-to-N-desmethylclozapine ratio measurement	UGT2B11 UGT2B10	1.73e-05	9	21	2	EFO_0600040
Disease	juvenile polyposis syndrome (implicated_via_orthology)	BMPR1A BMPR1B	3.75e-05	13	21	2	DOID:0050787 (implicated_via_orthology)
Disease	Eye Abnormalities	BMPR1A BMPR1B	6.52e-05	17	21	2	C0015393
Disease	phosphatidylcholine 36:4 measurement	UGT2B11 UGT2B28	7.33e-05	18	21	2	EFO_0010382
Disease	Gastric Adenocarcinoma	BMPR1A BMPR1B	4.69e-04	45	21	2	C0278701
Disease	diverticular disease	UGT2B11 BMPR1B STON1	6.04e-04	236	21	3	EFO_0009959
Disease	Diffuse Large B-Cell Lymphoma	IRF8 IMMP2L	7.00e-04	55	21	2	C0079744
Disease	pulmonary hypertension (is_marker_for)	BMPR1A BMPR1B	9.47e-04	64	21	2	DOID:6432 (is_marker_for)
Disease	interleukin 18 measurement	INHBA NLRC4	1.33e-03	76	21	2	EFO_0004581
Disease	testosterone measurement	UGT2B11 UGT2B10 INHBA TBL2 NLRC4	1.70e-03	1275	21	5	EFO_0004908

Protein segments in the cluster

Peptide	Gene	Start	Entry
VFWGIVFFDGCEKKK	APH1B	171	Q8WW43
VFFDGCEKKKWGILL	APH1B	176	Q8WW43
KAFECKEPGWFRFVF	ACCS	446	Q96QU6
VKLWEVFGEKCEFKG	ATG16L1	346	Q676U5
GKWRGEKVAVKVFFT	BMPR1B	221	O00238
CCKKQFFVSFKDIGW	INHBA	321	P08476
DGKFVFFKGDKHWVF	MMP14	376	P50281
GWVKRYIKAFCKGFF	IMMP2L	6	Q96T52
WGSGKCKALTKFKFV	NLRC4	186	Q9NPP4
KKIFCCFWFPEKGAI	FFAR4	331	Q5NUL3
IFKAWAVFKGKFKEG	IRF8	56	Q02556
GKWRGEKVAVKVFFT	BMPR1A	251	P36894
GIKGCEFKSWLFKFY	C7orf77	31	A4D0Y5
FCIWKGVKSTGKVVY	SLC6A12	226	P48065
VYFCVWKGVKSTGKI	SLC6A8	246	P48029
DNFWGKVTKEGKFVE	STON1	421	Q9Y6Q2
PQWKKFKSSFCEFIG	STAG2	166	Q8N3U4
FCIWKGVKSTGKVVY	SLC6A13	221	Q9NSD5
GKVFPFFAVWKKGSC	TRIM15	446	Q9C019
WALKCVKIGVDYFKV	TTC14	306	Q96N46
FCLFCFWKFARKGKK	UGT2B11	511	O75310
CLFCFWKFARKGKKG	UGT2B10	511	P36537
FCLFCFWKFARKGKK	UGT2B28	511	Q9BY64
WEVCFGKKGEFQEVV	TBL2	256	Q9Y4P3